Alliance Pharma plc

DB:DVL Stock Report

Market Cap: €399.1m

Alliance Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:DVL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Feb 25Sell€121Rowan Dartington & Co. Ltd., Asset Management ArmCompany164€0.74
06 Feb 25Sell€16,761Brown Shipley & Co., Asset Management ArmCompany22,836€0.73
05 Feb 25Sell€10,110Dimensional Fund Advisors LPCompany13,747€0.74
05 Feb 25Sell€26,540Brown Shipley & Co., Asset Management ArmCompany36,088€0.74
04 Feb 25Buy€5,286Canaccord Genuity Wealth (International) Ltd.Company7,167€0.74
04 Feb 25Sell€15,920Brown Shipley & Co., Asset Management ArmCompany21,620€0.74
04 Feb 25Sell€5,278Canaccord Genuity Wealth (International) Ltd.Company7,167€0.74
31 Jan 25Buy€43,885Alpine Associates Management Inc.Company59,800€0.73
31 Jan 25Sell€125,233Alpine Associates Management Inc.Company170,900€0.73
31 Jan 25Sell€2,130Brown Shipley & Co., Asset Management ArmCompany2,915€0.73
30 Jan 25Sell€11,280Brown Shipley & Co., Asset Management ArmCompany15,440€0.73
28 Jan 25Sell€57,647Janus Henderson Group plcCompany79,118€0.73
28 Jan 25Sell€6,509Brown Shipley & Co., Asset Management ArmCompany8,934€0.73
28 Jan 25Sell€3,548,746Rowan Dartington & Co. Ltd., Asset Management ArmCompany4,870,527€0.73
27 Jan 25Sell€2,258Rowan Dartington & Co. Ltd., Asset Management ArmCompany3,104€0.73
27 Jan 25Sell€19,937Brown Shipley & Co., Asset Management ArmCompany27,450€0.73
27 Jan 25Sell€1,161,454Premier Fund Managers Ltd.Company1,599,121€0.73
27 Jan 25Sell€154,533John DawsonIndividual212,418€0.73
24 Jan 25Buy€3,094,821Alpine Associates Management Inc.Company4,249,779€0.73
24 Jan 25Sell€1,395Rowan Dartington & Co. Ltd., Asset Management ArmCompany1,919€0.73
24 Jan 25Sell€9,824Brown Shipley & Co., Asset Management ArmCompany13,493€0.73
24 Jan 25Sell€4,369,024Lombard Odier Asset Management (Europe) Ltd.Company6,000,000€0.73
22 Jan 25Buy€3,245,859Glazer Capital, LLCCompany4,500,000€0.72
22 Jan 25Buy€32,671Caisse Fédérale de Crédit Mutuel,Asset Management ArmCompany45,198€0.72
22 Jan 25Sell€722,484John DawsonIndividual1,000,000€0.72
22 Jan 25Sell€9,173Rowan Dartington & Co. Ltd., Asset Management ArmCompany12,717€0.72
22 Jan 25Sell€4,696Brown Shipley & Co., Asset Management ArmCompany6,500€0.72
22 Jan 25Sell€3,256,500Lombard Odier Asset Management (Europe) Ltd.Company4,500,000€0.72
21 Jan 25Buy€3,972,975Glazer Capital, LLCCompany5,500,000€0.72
21 Jan 25Buy€722,359Samson Rock Capital LLPCompany1,000,000€0.72
21 Jan 25Sell€10,000Rowan Dartington & Co. Ltd., Asset Management ArmCompany13,844€0.72
21 Jan 25Sell€9,878Brooks MacDonald Asset ManagementCompany13,675€0.72
21 Jan 25Sell€1,088,519Artemis Investment Management LLPCompany1,506,895€0.72
21 Jan 25Sell€14,242Brown Shipley & Co., Asset Management ArmCompany19,716€0.72
21 Jan 25Sell€3,623,071Lombard Odier Asset Management (Europe) Ltd.Company5,007,401€0.72
20 Jan 25Buy€4,459,508Samson Rock Capital LLPCompany6,181,000€0.72
20 Jan 25Sell€1,598Brown Shipley & Co., Asset Management ArmCompany2,215€0.72
20 Jan 25Sell€7,616,147Lombard Odier Asset Management (Europe) Ltd.Company10,554,539€0.72
17 Jan 25Buy€3,932Evelyn Partners Group LimitedCompany5,441€0.72
17 Jan 25Buy€2,726,442Caisse Fédérale de Crédit Mutuel,Asset Management ArmCompany3,766,974€0.72
17 Jan 25Sell€34,561Brown Shipley & Co., Asset Management ArmCompany47,828€0.72
17 Jan 25Sell€3,355,867Lombard Odier Asset Management (Europe) Ltd.Company4,636,475€0.72
17 Jan 25Sell€12,727Evelyn Partners Group LimitedCompany17,612€0.72
17 Jan 25Sell€237,072John DawsonIndividual327,058€0.72
17 Jan 25Sell€6,645Canaccord Genuity Wealth (International) Ltd.Company9,183€0.72
16 Jan 25Buy€1,682,373Alpine Associates Management Inc.Company2,311,352€0.73
16 Jan 25Sell€33,047Rowan Dartington & Co. Ltd., Asset Management ArmCompany45,436€0.73
16 Jan 25Sell€40,407Brown Shipley & Co., Asset Management ArmCompany55,556€0.73
15 Jan 25Buy€593,619Alpine Associates Management Inc.Company814,922€0.73
15 Jan 25Sell€6,672Rowan Dartington & Co. Ltd., Asset Management ArmCompany9,163€0.73
15 Jan 25Sell€15,118Brown Shipley & Co., Asset Management ArmCompany20,770€0.73
14 Jan 25Buy€1,811,129Alpine Associates Management Inc.Company2,496,371€0.73
14 Jan 25Sell€100,123Brown Shipley & Co., Asset Management ArmCompany138,334€0.72
14 Jan 25Sell€5,394,653Artemis Investment Management LLPCompany7,441,304€0.72
13 Jan 25Buy€2,631,034Alpine Associates Management Inc.Company3,607,024€0.73
13 Jan 25Sell€13,109Canaccord Genuity Wealth (International) Ltd.Company18,000€0.73
13 Jan 25Sell€3,132Brown Shipley & Co., Asset Management ArmCompany4,300€0.73
13 Jan 25Sell€2,278,753Premier Fund Managers Ltd.Company3,129,030€0.73
13 Jan 25Sell€3,873Rowan Dartington & Co. Ltd., Asset Management ArmCompany5,318€0.73
10 Jan 25Sell€18,177Evelyn Partners Group LimitedCompany25,000€0.73
10 Jan 25Sell€6,035Canaccord Genuity Wealth (International) Ltd.Company8,300€0.73

Insider Trading Volume

Insider Buying: DVL insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of DVL?
Owner TypeNumber of SharesOwnership Percentage
Private Companies131,7520.0229%
Individual Insiders12,939,1562.25%
Employee Share Scheme13,295,9732.31%
Public Companies71,333,66512.4%
Institutions478,052,27783%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 88.56% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.8%
DBAY Advisors Limited
79,910,959€59.0m-47.1%47.77%
13.5%
Slater Investments Limited
73,115,658€54.0m1.51%4.92%
13.2%
Logistics Development Group plc
71,165,281€52.5m0.01%no data
4.63%
Glazer Capital, LLC
25,049,332€18.5m0%2.68%
3.07%
Artemis Investment Management LLP
16,576,144€12.2m-35.1%0.05%
2.79%
Alpine Associates Management Inc.
15,080,639€11.1m0%0.69%
2.78%
Van Lanschot Kempen Investment Management N.V.
15,019,017€11.1m0%0.08%
2.69%
RBC Global Asset Management Inc.
14,546,460€10.7m0%0.01%
2.65%
UBS Asset Management AG
14,337,713€10.6m22.3%no data
2.46%
Triton Investments Advisers Llp
13,295,973€9.8m0%no data
2.46%
Alliance Pharma Plc Employee Share Scheme(S)
13,295,973€9.8m0%no data
2.35%
John Dawson
12,678,245€9.4m0%no data
2.27%
Canaccord Genuity Wealth (International) Ltd.
12,260,907€9.1m-6.32%0.14%
1.87%
Janus Henderson Group plc
10,102,140€7.5m4.94%no data
1.76%
Evelyn Partners Investment Management LLP
9,512,123€7.0m-2.57%0.08%
1.73%
Kredietrust Luxembourg SA
9,336,913€6.9m-3.65%0.21%
1.7%
Evelyn Partners Group Limited
9,192,737€6.8m0%0.84%
1.63%
Caisse Fédérale de Crédit Mutuel,Asset Management Arm
8,795,198€6.5m0%36.03%
1.55%
LOYS AG
8,391,167€6.2m0%1.14%
1.53%
Canaccord Genuity Asset Management Limited
8,250,000€6.1m24.1%0.25%
1.49%
Dimensional Fund Advisors LP
8,064,913€6.0m123%no data
1.49%
Brown Shipley & Co., Asset Management Arm
8,040,431€5.9m0%0.65%
1.48%
Samson Rock Capital LLP
8,000,000€5.9m0%0.87%
1.48%
Brooks MacDonald Asset Management
7,973,934€5.9m-39%0.61%
1.24%
Rowan Dartington & Co. Ltd., Asset Management Arm
6,714,213€5.0m-51.2%0.57%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/11 01:17
End of Day Share Price 2025/02/11 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Alliance Pharma plc is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Samuel EnglandBerenberg
Julie SimmondsCanaccord Genuity
Mark BrewerCavendish